What does CUSIP 558868105 represent in this 13F holders report?

CUSIP 558868105 is the security identifier for MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock in Q3 2022?

133 institutional investors reported MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock for Q3 2022. Use the holders table for investor-level position and value details.

MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL)

CUSIP: 558868105

Q3 2022 13F Holders as of 30 Sep 2022

Security type / class: Equity / Common Stock
Total 13F shares: 11,751,595
Total 13F value: $763,791,382
Share change: -286,070
Put/Call ratio: 153%
SEC-reported price per share: $64.99
Number of holders: 133
Value change: -$25,263,206
Number of buys: 68
Number of sells: 47
Shares outstanding: 23,203,174

Security key

558868105

Report period

Q3 2022

Institutions

133

Top holders

MDGL full security history Ownership snapshot Full 13F holder table MADRIGAL PHARMACEUTICALS, INC. SEC filings MADRIGAL PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Avoro Capital Advisors LLC

Disclosed value leader

Avoro Capital Advisors LLC

Comparable rows

15/15

Latest evidence

30 Jun 2022

13F Lead comparable stake: 6.6% Showing 1-6 of 15 holder rows.

Quick read

Avoro Capital Advisors LLC leads the comparable SEC ownership view at 6.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Avoro Capital Advisors LLC's linked filing trail.

Comparable ownership Top 5

Avoro Capital Advisors LLC 6.6%

BAKER BROS. ADVISORS LP 6.5%

VANGUARD GROUP INC 5.3%

ARMISTICE CAPITAL, LLC 4.7%

BlackRock Finance, Inc. 4.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Avoro Capital Advisors LLC	13F Company 13F	6.6%	$109,875,000 1,535,000 shares	—	30 Jun 2022
BAKER BROS. ADVISORS LP	13F Company 13F	6.5%	$107,314,000 1,499,213 shares	—	30 Jun 2022
VANGUARD GROUP INC	13F Company 13F	5.3%	$88,186,000 1,231,983 shares	—	30 Jun 2022
ARMISTICE CAPITAL, LLC	13F Company 13F	4.7%	$78,738,000 1,100,000 shares	—	30 Jun 2022
BlackRock Finance, Inc.	13F Company 13F	4.3%	$71,468,000 998,446 shares	—	30 Jun 2022
Deep Track Capital, LP	13F Company 13F	3.9%	$64,780,000 905,000 shares	—	30 Jun 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

133

11,751,595

Rows available

133

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

130

Q3 2022 holders

133

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 value	Q3 2022 value	Value change	Value Chg %